| Sep'19 | Sep'18 | Sep'17 | Sep'16 | Sep'15 | Sep'14 | Sep'13 |
|---|---|---|---|---|---|---|
Cash flows from operating activities: | ||||||
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | ||||||
448,466 | 568,440 | 374,187 | 288,232 | 236,976 | 149,459 | 70,366 |
Adjustments to reconcile net income to net cash (used in) provided by operating activities | ||||||
Depreciation and amortization | ||||||
592,573 | 596,182 | 508,212 | 495,765 | 504,033 | 521,581 | 542,136 |
Deferred income taxes | ||||||
40,503 | -104,289 | -37,856 | 52,416 | -4,108 | 37,372 | -17,791 |
Share-based compensation expense | ||||||
55,280 | 88,276 | 65,155 | 56,942 | 66,416 | 96,332 | 19,417 |
Net gain on sale of Healthcare Technologies | ||||||
139,165 | 0 | 0 | - | - | - | - |
Changes in operating assets and liabilities: | ||||||
Accounts Receivable | ||||||
78,771 | 45,891 | 111,423 | 32,859 | -81,284 | 226,756 | 108,583 |
Inventories | ||||||
49,732 | 40,187 | 21,147 | 9,625 | 29,587 | 19,810 | 34,950 |
Prepayments and Other Current Assets | ||||||
37,854 | -42,450 | -95,536 | 64,663 | -9,763 | 77,609 | 49,224 |
Accounts Payable | ||||||
17,680 | 26,658 | 93,965 | 4,486 | -46,422 | 9,657 | 74,462 |
Accrued Expenses | ||||||
193,532 | -111,386 | 26,804 | 67,600 | 4,474 | -113,193 | 161,441 |
Payments made to clients on contracts | ||||||
40,073 | 0 | 0 | - | - | - | - |
Changes in other noncurrent liabilities | ||||||
18,904 | 1,576 | 31,959 | -33,711 | -52,136 | -9,034 | -26,506 |
Changes in other assets | ||||||
41,436 | 2,225 | 9,342 | 10,189 | -13,595 | -10,123 | -30,581 |
Other operating activities | ||||||
4,320 | 32,271 | 36,776 | 52,920 | 17,904 | 20,037 | 34,558 |
Net cash (used in) provided by operating activities | ||||||
984,227 | 1,051,875 | 1,052,826 | 867,314 | 802,192 | 398,159 | 695,907 |
Cash flows from investing activities: | ||||||
Purchases of property and equipment and other | ||||||
503,090 | 628,604 | 552,729 | 512,532 | 524,384 | 545,194 | 392,932 |
Disposals of property and equipment | ||||||
17,871 | 10,491 | 18,906 | 26,824 | 19,128 | 28,494 | 11,298 |
Proceeds from divestiture | ||||||
293,711 | 0 | 0 | - | - | 24,000 | 919 |
Working capital other than cash acquired | ||||||
-10,634 | -37,985 | -8,114 | -10,226 | 143 | 540 | 547 |
Property and equipment | ||||||
3,320 | 283,447 | 2,273 | 32,989 | 0 | 6,681 | 183 |
Additions to goodwill, other intangible assets and other assets, net | ||||||
52,177 | 1,994,822 | 147,963 | 176,614 | 3,234 | 14,235 | 21,836 |
Proceeds from governmental agencies related to property and equipment | ||||||
23,025 | 0 | 0 | - | - | - | - |
Other investing activities | ||||||
-3,825 | 6,879 | 2,539 | -5,340 | -4,299 | -8,934 | -17,893 |
Net cash (used in) provided by investing activities | ||||||
-209,521 | -2,865,276 | -678,484 | -679,745 | -504,334 | -505,222 | -385,388 |
Cash flows from financing activities: | ||||||
Proceeds from long-term borrowings | ||||||
77,630 | 3,177,313 | 3,851,417 | 1,399,988 | 71,926 | 1,570,818 | 3,080,464 |
Payments of long-term borrowings | ||||||
654,560 | 973,689 | 3,911,992 | 1,363,534 | 209,621 | 1,978,606 | 3,314,853 |
Net change in funding under the Receivables Facility | ||||||
0 | -254,200 | -13,800 | -82,000 | 0 | 50,000 | 36,200 |
Payments of dividends | ||||||
108,439 | 103,115 | 100,813 | 92,074 | 81,898 | 52,186 | 0 |
Proceeds from initial public offering, net | ||||||
- | - | - | - | - | 524,081 | 0 |
Proceeds from issuance of common stock | ||||||
39,087 | 21,507 | 28,779 | 35,705 | 39,946 | 4,408 | 5,597 |
Distribution in connection with spin-off of Seamless | ||||||
- | - | - | - | - | - | 47,352 |
Repurchase of common stock | ||||||
50,000 | 24,410 | 100,000 | 749 | 50,176 | 4,730 | 42,399 |
Other financing activities | ||||||
-38,610 | -49,253 | -42,277 | -54,741 | -57,309 | -6,030 | -53,926 |
Net cash provided by (used in) financing activities | ||||||
-734,892 | 1,794,153 | -288,686 | -157,405 | -287,132 | 107,755 | -336,269 |
Effect of foreign exchange rates on cash and cash equivalents | ||||||
-8,196 | -4,524 | 561 | - | - | - | - |
Increase (decrease) in cash and cash equivalents | ||||||
31,618 | -23,772 | 86,217 | 30,164 | 10,726 | 692 | -25,750 |